Literature DB >> 15240664

K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity.

Heike Wulff1, Hans-Günther Knaus, Michael Pennington, K George Chandy.   

Abstract

Using whole-cell patch-clamp, fluorescence microscopy and flow cytometry, we demonstrate a switch in potassium channel expression during differentiation of human B cells from naive to memory cells. Naive and IgD(+)CD27(+) memory B cells express small numbers of the voltage-gated Kv1.3 and the Ca(2+)-activated intermediate-conductance IKCa1 channel when quiescent, and increase IKCa1 expression 45-fold upon activation with no change in Kv1.3 levels. In contrast, quiescent class-switched memory B cells express high levels of Kv1.3 ( approximately 2000 channels/cell) and maintain their Kv1.3(high) expression after activation. Consistent with their channel phenotypes, proliferation of naive and IgD(+)CD27(+) memory B cells is suppressed by the specific IKCa1 inhibitor TRAM-34 but not by the potent Kv1.3 blocker Stichodactyla helianthus toxin, whereas the proliferation of class-switched memory B cells is suppressed by Stichodactyla helianthus toxin but not TRAM-34. These changes parallel those reported for T cells. Therefore, specific Kv1.3 and IKCa1 inhibitors may have use in therapeutic manipulation of selective lymphocyte subsets in immunological disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240664     DOI: 10.4049/jimmunol.173.2.776

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  78 in total

1.  Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease.

Authors:  Srikant Rangaraju; Marla Gearing; Lee-Way Jin; Allan Levey
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Targeting ion channels for the treatment of autoimmune neuroinflammation.

Authors:  Stefan Bittner; Sven G Meuth
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

3.  Voltage-dependent slowly activating anion current regulated by temperature and extracellular pH in mouse B cells.

Authors:  Joo Hyun Nam; Hai Feng Zheng; Ki Hyun Earm; Jae Hong Ko; Ik-Jae Lee; Tong Mook Kang; Tae Jin Kim; Yung E Earm; Sung Joon Kim
Journal:  Pflugers Arch       Date:  2006-06-07       Impact factor: 3.657

4.  Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells.

Authors:  Shekhar Srivastava; Kyung Ko; Papiya Choudhury; Zhai Li; Amanda K Johnson; Vivek Nadkarni; Derya Unutmaz; William A Coetzee; Edward Y Skolnik
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

5.  The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke.

Authors:  Yi-Je Chen; Girija Raman; Silke Bodendiek; Martha E O'Donnell; Heike Wulff
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-13       Impact factor: 6.200

6.  Arachidonic acid-induced activation of large-conductance potassium channels and membrane hyperpolarization in mouse B cells.

Authors:  Haifeng Zheng; Joo Hyun Nam; Yen Hoang Nguen; Tong Mook Kang; Tae Jin Kim; Yung E Earm; Sung Joon Kim
Journal:  Pflugers Arch       Date:  2008-01-24       Impact factor: 3.657

Review 7.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

8.  Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus.

Authors:  Stella A Nicolaou; Peter Szigligeti; Lisa Neumeier; Susan Molleran Lee; Heather J Duncan; Shashi K Kant; Anne Barbara Mongey; Alexandra H Filipovich; Laura Conforti
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

9.  The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.

Authors:  Xiaoqin Hua; Tobias Deuse; Yi-Je Chen; Heike Wulff; Mandy Stubbendorff; Ralf Köhler; Hiroto Miura; Florian Länger; Hermann Reichenspurner; Robert C Robbins; Sonja Schrepfer
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

10.  Modulation of Lymphocyte Potassium Channel KV1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin.

Authors:  Seow Theng Ong; Saumya Bajaj; Mark R Tanner; Shih Chieh Chang; Bankala Krishnarjuna; Xuan Rui Ng; Rodrigo A V Morales; Ming Wei Chen; Dahai Luo; Dharmeshkumar Patel; Sabina Yasmin; Jeremy Jun Heng Ng; Zhong Zhuang; Hai M Nguyen; Abbas El Sahili; Julien Lescar; Rahul Patil; Susan A Charman; Edward G Robins; Julian L Goggi; Peng Wen Tan; Pragalath Sadasivam; Boominathan Ramasamy; Siddana V Hartimath; Vikas Dhawan; Janna Bednenko; Paul Colussi; Heike Wulff; Michael W Pennington; Serdar Kuyucak; Raymond S Norton; Christine Beeton; K George Chandy
Journal:  ACS Pharmacol Transl Sci       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.